mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein
- PMID: 8628312
- PMCID: PMC231233
- DOI: 10.1128/MCB.16.5.2445
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein
Abstract
The mdm-2 gene encodes a 90-kDa polypeptide that binds specifically to the p53 tumor suppressor protein. This physical interaction results in the inhibition of the transcriptional functions of p53 (J. Chen, J. Lin, and A. J. Levine, Mol. Med. 1:142-152, 1995, and J. Momand, G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine, Cell 69:1237-1245, 1992). Experiments are described that demonstrate the ability of mdm-2 to abrogate both the p53-mediated cell cycle arrest and the apoptosis functions. In addition, the results presented here suggest that mdm-2 binding to p53 and the resultant inhibition of p53 transcription functions are critical for reversing p53-mediated cell cycle arrest. The N-terminal half or domain of the mdm-2 protein is sufficient to regulate these biological activities of p53, consistent with the possibility that the highly conserved central acidic region and the C-terminal putative zinc fingers of mdm-2 may encode other functions.
Similar articles
-
Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.Mol Med. 1995 Jan;1(2):142-52. Mol Med. 1995. PMID: 8529093 Free PMC article.
-
Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.Tumour Biol. 2003 May-Jun;24(3):130-9. doi: 10.1159/000073842. Tumour Biol. 2003. PMID: 14610316
-
Mapping of the p53 and mdm-2 interaction domains.Mol Cell Biol. 1993 Jul;13(7):4107-14. doi: 10.1128/mcb.13.7.4107-4114.1993. Mol Cell Biol. 1993. PMID: 7686617 Free PMC article.
-
The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.Hum Mutat. 2014 Jun;35(6):728-37. doi: 10.1002/humu.22524. Epub 2014 Mar 6. Hum Mutat. 2014. PMID: 24488925 Free PMC article. Review.
-
Targeting the p53 pathway.Surg Oncol Clin N Am. 2013 Oct;22(4):747-64. doi: 10.1016/j.soc.2013.06.003. Epub 2013 Jul 30. Surg Oncol Clin N Am. 2013. PMID: 24012397 Free PMC article. Review.
Cited by
-
Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.Curr Hematol Malig Rep. 2019 Oct;14(5):460-468. doi: 10.1007/s11899-019-00538-4. Curr Hematol Malig Rep. 2019. PMID: 31372878 Review.
-
Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.Hum Cell. 2009 May;22(2):49-54. doi: 10.1111/j.1749-0774.2009.00068.x. Hum Cell. 2009. PMID: 19379464
-
Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.PLoS One. 2014 Feb 5;9(2):e88219. doi: 10.1371/journal.pone.0088219. eCollection 2014. PLoS One. 2014. PMID: 24505435 Free PMC article.
-
A unique glucose-dependent apoptotic pathway induced by c-Myc.Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1511-6. doi: 10.1073/pnas.95.4.1511. Proc Natl Acad Sci U S A. 1998. PMID: 9465046 Free PMC article.
-
Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis.Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2105-10. doi: 10.1073/pnas.040378897. Proc Natl Acad Sci U S A. 2000. PMID: 10681424 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous